MH Pharma

MH Pharma is a specialty pharmaceutical company based in Turkey that focuses on the development, licensing, and distribution of high-tech medical products, particularly in the fields of oncology, hematology, and rare diseases. The company specializes in providing access to orphan drugs and advanced therapies for life-threatening conditions within the Turkish and regional markets. MH Pharma maintains a diverse portfolio of hospital-use products, including anti-infectives, intensive care medications, and targeted cancer therapies. By partnering with international biotechnology and pharmaceutical firms, the company bridges the gap between innovative global research and local patient needs. Their business model emphasizes regulatory expertise and a robust supply chain for specialized medicinal products.